UBS Group just sliced their target for CVS Health from $71.00 to $67.00, maintaining a 'neutral' stance. Despite this cut, ...

Crude oil futures fell as the market turns its focus to the August 1 deadline for US tariffs to go into effect, as lingering ...

Oil futures fall for a third consecutive session with the market turning its focus to the deadline for U.S. tariffs to go into effect and the next OPEC+ meeting to decide on production levels for ...

Centene Corp. (NYSE:CNC) is one of the most oversold S&P 500 stocks so far in 2025. On July 2, Centene’s share price plunged ...

On Monday, a frenzy of activity in shares of Opendoor Technologies Inc. saw more than 1.8 billion shares of the iBuyer change hands. That was roughly three times the company's public float. Opendoor ...

There is a new player making waves in an industry dominated by big banks. Imprint is a five year old startup taking on ...

SoftBank and OpenAI’s partnership on a $500 billion project to build AI data centers stalls six months after launch.

MainStreet Bancshares Inc (MNSB) is expected to report $0.42 for 2Q. Mercantile Bank Corp (MBWM) is expected to report $1.24 for 2Q. Mueller Industries Inc (MLI) is expected to report $1.61 for 2Q.

Fintel reports that on July 21, 2025, Mizuho downgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) from Outperform to Neutral. Analyst Price Forecast Suggests 274.14% Upside As of July 17, ...

Jared Holz, Mizuho health care sector strategist, joins 'The Exchange' to discuss the pain in the health care sector and if ...

To date, roughly 290,000 horizontals have been landed in tight rock in the Lower 48 and 270,000 locations remain, Mizuho ...

Stocks trading under $10 can be attractive for investors looking to scoop up some cheap shares. Unfortunately, quality stocks trading for less than $10 are few and far between. Stock prices at ...